This inventor holds 1 USPTO granted patent. Top assignee: Pacesetter, Inc.. Active years: 2007.
Company Filing History:
Years Active: 2007
Title: Innovations by John C. Guthrie in Cardiac Stimulation Technology
Introduction
John C. Guthrie is an accomplished inventor based in Wentzville, MO (US). He has made significant contributions to the field of cardiac stimulation technology. His innovative work focuses on improving the functionality and reliability of biventricular pacing systems.
Latest Patents
Guthrie holds a patent for a "System and method for implementing autocapture within biventricular implantable cardiac stimulation systems." This patent describes a biventricular pacing system that includes an automatic capture verification system. This system verifies the capture of left ventricular pacing pulses on a beat-by-beat basis. Additionally, it features a loss of capture recovery system that delivers a backup safety pulse in the event of loss of capture detected in either the right or left ventricle. The patent also includes an automatic stimulation threshold search system for measuring the capture threshold of both left and right ventricles based on various triggers. Furthermore, an automatic output regulation system is provided to set the pacing amplitude to levels sufficient to ensure capture plus a safety margin.
Career Highlights
Guthrie's career is marked by his dedication to advancing cardiac technology. His work at Pacesetter, Inc. has been instrumental in developing innovative solutions for patients with heart conditions. His patent reflects his commitment to enhancing the effectiveness of cardiac pacing systems.
Collaborations
Guthrie has collaborated with notable colleagues, including Scott Patrick Simon and Daniel C. Carlblom. These partnerships have contributed to the development of cutting-edge technologies in the field of cardiac stimulation.
Conclusion
John C. Guthrie's contributions to cardiac stimulation technology exemplify his innovative spirit and dedication to improving patient care. His patent showcases the advancements in biventricular pacing systems, highlighting the importance of reliability and safety in cardiac treatments.